Discover and read the best of Twitter Threads about #PaedsID
Most recents (4)
1/
In the newest Febrile Digest, we chat about SCORTCH as a framework for congenital infections. Check out our guest's overview: pubmed.ncbi.nlm.nih.gov/32586930/
Some nice figs below fr the paper 👇
But where did "TORCH" come fr? I tried to take a look in this 🧵
#IDTwitter #IDMedEd
In the newest Febrile Digest, we chat about SCORTCH as a framework for congenital infections. Check out our guest's overview: pubmed.ncbi.nlm.nih.gov/32586930/
Some nice figs below fr the paper 👇
But where did "TORCH" come fr? I tried to take a look in this 🧵
#IDTwitter #IDMedEd
2/ From what I could tell, the ToRCH acronym originated in the 1970s and has been attributed to Dr. Nahmias: nature.com/articles/pr197…
3/
There was a proposal from Harold Fuerst for "STORCH" in 1975, to include the omitted syphilis
publications.aap.org/pediatrics/art…
There was a proposal from Harold Fuerst for "STORCH" in 1975, to include the omitted syphilis
publications.aap.org/pediatrics/art…
Should #children be vaccinated against #COVID19?
Our review outlines the points to consider in weighing up whether all healthy children under 12y should be vaccinated against COVID-19.
bit.ly/2ZYyPi0
#medpeds #IDTwitter #PaedsID #tweetiatrician #paediatrics
🧵1/n
Our review outlines the points to consider in weighing up whether all healthy children under 12y should be vaccinated against COVID-19.
bit.ly/2ZYyPi0
#medpeds #IDTwitter #PaedsID #tweetiatrician #paediatrics
🧵1/n
As specialists in paediatric #InfectiousDiseases and #Vaccinology, we recognise enormous benefits of and strongly support child vaccination programmes
@Dr_Petzi @PittetLaure @adamhfinn @ajpollard1 @nigeltwitt
@unifr @unige_en @BristolUni @OxfordVacGroup @MCRI_for_kids @UniMelb
@Dr_Petzi @PittetLaure @adamhfinn @ajpollard1 @nigeltwitt
@unifr @unige_en @BristolUni @OxfordVacGroup @MCRI_for_kids @UniMelb
Our review highlights that the balance of risks and benefits of COVID-19 vaccination in children is more complex than in adults as the relative harms from vaccination and disease are less well established in this age group.
@ASIDANZ @ESPIDsociety @WSPID @PIDSociety @DFTBubbles
@ASIDANZ @ESPIDsociety @WSPID @PIDSociety @DFTBubbles
#LongCOVID
We reviewed 14 studies of persisting symptoms following #COVID19 in #children & #adolescents
Most had major limitations and should be interpreted with caution.
True risk is likely to be nearer 1 in 100 than often quoted 1 in 7.
#medpeds #IDTwitter
(Long) 🧵1/n
We reviewed 14 studies of persisting symptoms following #COVID19 in #children & #adolescents
Most had major limitations and should be interpreted with caution.
True risk is likely to be nearer 1 in 100 than often quoted 1 in 7.
#medpeds #IDTwitter
(Long) 🧵1/n
@Dr_Petzi @PittetLaure @MCRI_for_kids @RCHMelbourne @UniMelbMDHS @ASIDANZ @ESPIDsociety @ESPR_EBN @WSPID @PIDSociety @DFTBubbles @PIDJournal
#medpeds #IDTwitter #tweetiatrician #paediatrics #pediatrics #PaedsID #PedsID #PedID #PID
#medpeds #IDTwitter #tweetiatrician #paediatrics #pediatrics #PaedsID #PedsID #PedID #PID
The 14 studies involved 19,426 children & adolescents.
Common persistent symptoms reported 4-12 weeks after acute #COVID19 were:
•headache
•fatigue
•sleep disturbance
•concentration difficulties
•abdominal pain.
Symptoms rarely lasted more than 12 weeks.
Common persistent symptoms reported 4-12 weeks after acute #COVID19 were:
•headache
•fatigue
•sleep disturbance
•concentration difficulties
•abdominal pain.
Symptoms rarely lasted more than 12 weeks.
To reassure parents, a reminder of some key facts about #COVID in #children:
Â
#SARSCoV2 infection remains asymptomatic or mild in the vast majority of children, even with the #DeltaVariant. Hospitalisation and deaths from COVID are still rare in this age group.
1/n 🧵
Â
#SARSCoV2 infection remains asymptomatic or mild in the vast majority of children, even with the #DeltaVariant. Hospitalisation and deaths from COVID are still rare in this age group.
1/n 🧵
However, the greater transmissibility of the Delta variant means there is more COVID in *all* age groups, including children, so we will see more paediatric cases.
As a large number of older people are now vaccinated, the increase is blunted in the elderly so, compared with earlier in the pandemic, a higher *proportion* of current cases will be in children: this can give the mistaken impression that the Delta variant is targeting children.
